Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

China flag China · Delayed Price · Currency is CNY
92.50
-1.94 (-2.05%)
At close: Mar 3, 2026
13.30%
Market Cap 32.52B
Revenue (ttm) 6.29B
Net Income (ttm) 1.04B
Shares Out 359.72M
EPS (ttm) 2.86
PE Ratio 32.32
Forward PE 25.42
Dividend 1.10 (1.16%)
Ex-Dividend Date Jun 26, 2025
Volume 5,025,532
Average Volume 3,537,801
Open 94.24
Previous Close 94.44
Day's Range 91.40 - 94.98
52-Week Range 59.90 - 125.50
Beta 0.23
RSI 32.80
Earnings Date Mar 31, 2026

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 9,595
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002821
Full Company Profile

Financial Performance

In 2024, SHE:002821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial Statements

News

There is no news available yet.